# REPONEX PHARMACEUTICALS A/S

**CVR:** 30082346
**Status:** active
**Company type:** Aktieselskab
**Founded:** 2006-12-04
**Industry:** 212000, Fremstilling af farmaceutiske præparater
**Address:** Slotsmarken 12 1. th, 2970 Hørsholm
**Employees:** 2 (2-4)
**Capital:** 849,867.5 DKK
**Website:** www.reponex.dk

> **Pro tier:** CDS credit-health score (0–100) for this company is available on Pro. Upgrade: https://companydata.dk/priser

## Financials


| Year | Revenue | Profit | Equity | Assets | Employees |

|------|---------|--------|--------|--------|-----------|

| 2025 | 0 DKK | -6,570,000 DKK | 4,645,000 DKK | 7,301,000 DKK | - |

> **Pro tier:** 13 additional years of financial statements (2012–2024) available on Pro — including full revenue, profit, equity, and assets per year. Upgrade: https://companydata.dk/priser

## Owners (1)


- **Pharma Equity Group A/S**, CVR 26791413, VIRKSOMHED, 1% ownership, since 2023-03-24

## Board of directors (16)


- **Troels Peter Troelsen**, BESTYRELSESMEDLEM, since 2015-03-17
- **Troels Peter Troelsen**, FORMAND, since 2016-06-21
- **Troels Peter Troelsen**, BESTYRELSESMEDLEM, since 2019-06-17
- **Troels Peter Troelsen**, NÆSTFORMAND, since 2021-06-22
- **Jacob Rosenberg**, FORMAND, since 2015-03-17
- **Henrik Bulskov**, BESTYRELSESMEDLEM, since 2015-03-17
- **Katrine Hoff Schlichtkrull**, BESTYRELSESMEDLEM, since 2021-06-22
- **Peter Mørch Eriksen**, BESTYRELSESMEDLEM, since 2023-03-31
- **Erik Lennard Vitting Skovbjerg**, BESTYRELSESMEDLEM, since 2016-06-21
- **Christian Vinding Thomsen**, BESTYRELSESMEDLEM, since 2021-06-22
- **Christian Vinding Thomsen**, FORMAND, since 2022-10-11
- **Lisbeth Thyregod**, BESTYRELSESMEDLEM, since 2017-05-31
- **Sigbjørn Georg Nielsen Kjærgård**, FORMAND, since 2019-06-17
- **Sigbjørn Georg Nielsen Kjærgård**, BESTYRELSESMEDLEM, since 2022-10-11
- **Charlotte Pahl**, BESTYRELSESMEDLEM, since 2018-05-14
- **Mette Zacho**, BESTYRELSESMEDLEM, since 2023-03-31

## Executive management (11)


- **Mikael Thiesen**, DIREKTØR, since 2006-12-04
- **Christian Henrik Tange**, ADM. DIR., since 2025-12-19
- **Torsten Bjørn**, DIREKTØR, since 2016-04-19
- **Thomas Kaas Selsø**, DIREKTØR, since 2022-03-01
- **Thomas Kaas Selsø**, ADM. DIR., since 2023-06-14
- **Henrik Lasse Lindblad**, ADM. DIR., since 2010-02-02
- **Sigbjørn Georg Nielsen Kjærgård**, ADM. DIR., since 2022-10-11
- **Michael Secher**, DIREKTØR, since 2008-12-31
- **Jon Steffen Therkildsen**, DIREKTØR, since 2007-05-15
- **Klaus Snej Jensen**, ADM. DIR., since 2021-03-01
- **Sebastian Bo Jakobsen**, ADM. DIR., since 2025-04-01

## Secondary names

- Heslet Pharma A/S
- TRIFOILIUM A/S

## Contact


- Website: www.reponex.dk

---
*Free-tier view. Pro subscribers additionally see: 13 additional years of financial statements (2012–2024) available on Pro — including full revenue, profit, equity, and assets per year. CDS credit-health score (0–100) for this company is available on Pro. See https://companydata.dk/priser*

Source: Danish public registries (CVR / Ejendomsvurderingen). Canonical: https://companydata.dk/da/virksomhed/30082346-reponex-pharmaceuticals-a-s